← All trials
NCT04965662
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2018
- Primary completion
- Mar 16, 2021
- Completion date
- Mar 16, 2021
- First posted
- Jul 16, 2021
- Last posted
- Jul 22, 2021
- Enrollment
- 139
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LondonLead sponsor
- ViiV HealthcareCollaborator
- Gilead SciencesCollaborator
- Guy's and St Thomas HospitalStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.